Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.

Source:http://linkedlifedata.com/resource/pubmed/id/9462724

Int. J. Cancer 1998 Jan 19 75 2 310-6

Download in:

View as

General Info

PMID
9462724